Donald Trump’s pick to lead the federal health agency has vowed to replace hundreds of staffers and shift research away from infectious diseases and vaccines. Such an overhaul could imperil the development of life-saving treatments,
Bird flu has been detected in a Georgia commercial poultry flock for the first time since a countrywide outbreak in 2022.
The US Centers for Disease Control and Prevention is urging hospitals to accelerate advanced testing of people they suspect may have bird flu.
To improve and streamline oversight of risky pathogen research, President-elect Donald Trump should create a new biosafety and biosecurity agency.
Investigators from Mass General Brigham have found that a method originally designed for cancer detection can also identify and monitor even tiny amounts of SARS-CoV-2 intact viral particles in blood and other fluids from patients with acute COVID-19 infections,
For the first time since the 2022 countrywide outbreak, bird flu hit a poultry producer in Georgia, the nation's top state for chicken production. The state Department of Agriculture announced Friday that the agency has detected a case of Highly Pathogenic Avian Influenza at a commercial poultry producer in Elbert County,
President Trump announced he's pulling the U.S. from the WHO. Now researchers are scrambling to understand what that means for the H5N1 bird flu pandemic.
On Friday, Jan. 17, the Maryland Department of Natural Resources (DNR) announced that it has increased its efforts to collect dead birds that could be carrying
Investigators from Mass General Brigham have found that a method originally designed for cancer detection can also identify and monitor even tiny
A sick snow goose found in West Philadelphia earlier this month has tested positive for the avian influenza A(H5), making it the first bird in the city to test positive
Cats and other animals can be susceptible to the virus, especially if they spend any amount of time outside. Cats, for example, can contract the virus if they eat or kill a bird that has the virus.
Vast Therapeutics, a clinical-stage life science company, today announced that it has been awarded a nearly two million dollar grant from the National Institutes of Health (NIH).1 The two-year project